Does Kesimpta Require a Loading Dose?
No, Kesimpta (ofatumumab) does not require a loading dose. The standard starting regimen is 20 mg administered subcutaneously at Week 0, followed by 20 mg every 4 weeks beginning at Week 4.[1]
How Is Kesimpta Dosed for Multiple Sclerosis?
For relapsing forms of multiple sclerosis in adults, treatment begins with a single 20 mg subcutaneous injection on Day 0 (Week 0). Maintenance dosing is then 20 mg every 4 weeks starting at Week 4. No initial higher or multi-dose loading phase is needed, unlike some other MS therapies.[1][2]
Why No Loading Dose Compared to Other MS Drugs?
Kesimpta achieves rapid B-cell depletion with its first dose, reaching near-complete depletion by Week 3 without needing escalation. This differs from drugs like Ocrevus (ocrelizumab), which uses a loading schedule of two 300 mg infusions 2 weeks apart, or Rituxan (rituximab), which often requires multiple loading infusions for saturation. Kesimpta's self-administered pen format supports this straightforward monthly schedule.[1][3]
What If a Dose Is Missed?
If a maintenance dose is missed by more than 1 week, administer as soon as possible and restart the 4-week interval from that dose. No special loading or catch-up is required.[1]
Common Patient Concerns with Dosing
Patients report easier adherence due to the at-home, once-monthly injections without loading complexity. Injection-site reactions occur in about 21% of users, typically mild and decreasing after the first dose.[1][4]
[1]: Kesimpta Prescribing Information (Novartis)
[2]: FDA Label for Kesimpta
[3]: Ocrevus Prescribing Information (Genentech)
[4]: Kesimpta Clinical Trial Data (ASCLEPIOS I/II)